1. THU0145 A multi-biomarker disease activity (MBDA) score measures rheumatoid arthritis disease activity in patients treated with the JAK inhibitor tofacitinib. (23rd January 2014) Authors: Yamaoka, K.; Kubo, S.; Sonomoto, K.; Hirata, S.; Voinov, A.; Rowe, M.; Cavet, G.; Saito, K.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗